Skip to main content
Arnav Srivastava, MD, Urology, Ann Arbor, MI

ArnavSrivastavaMDMPH

Urology • Ann Arbor, MI

Minimally Invasive Surgery, Surgical Oncology

Urologic Oncology Fellow

Join to view full profile

Dr. Srivastava is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Srivastava's full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    Ann Arbor, MI 48109

Summary

  • Dr. Arnav Srivastava is an urologic oncology fellow at the University of Michigan. He obtained his MD, MPH from The Johns Hopkins University School of Medicine in Baltimore, MD. He then completed his urology residency at Rutgers Robert Wood Johnson University Hospital in New Brunswick, NJ.

    He has clinical interests in urologic malignancies including prostate, bladder, and kidney cancer.

    He has research interests in health services research, health economics, insurance design, and biomarker development.

    He has more than 50 publications and over 1000 citings.

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Urologic Surgical Oncology, 2023 - 2026
  • Rutgers Health/Robert Wood Johnson Medical School
    Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Urology, 2018 - 2023
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2017

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2023 - 2026
  • NJ State Medical License
    NJ State Medical License 2019 - 2025

Publications & Presentations

PubMed

Press Mentions

  • Implant Shows Promise for Tumor-Specific Treatment in Prostate Cancer
    Implant Shows Promise for Tumor-Specific Treatment in Prostate CancerFebruary 5th, 2025
  • Financial Incentive Did Not Increase Prostate Cancer Active Surveillance Adoption
    Financial Incentive Did Not Increase Prostate Cancer Active Surveillance AdoptionJanuary 14th, 2025
  • Payment Incentives Fail to Push Physicians Toward MRI Surveillance of Low-Risk Prostate Cancer
    Payment Incentives Fail to Push Physicians Toward MRI Surveillance of Low-Risk Prostate CancerJanuary 10th, 2025
  • Join now to see all

Dr. Arnav Srivastava, Dr. Arnav Srivastava, MD, Dr. A Srivastava